October 4, 2026 3:00 AM
Proponents of BPC-157, the “Wolverine” peptide, tout injury recovery and pain relief despite limited human evidence to establish safety and effectiveness. Until the potential for adverse reactions is better understood, experts advise against unapproved peptides.
